Sign up for free insights newsletter
Astellas Pharma Inc.

Astellas Pharma Inc.

4503Tokyo Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

¥2,607.00
+0.27%
End of day
Market Cap

$3.94T

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.1414.863.5210.307.407.89
Calmar61.537.5216.4910.6418.91
Sharpe-0.106.372.115.674.154.16
Omega0.991.961.351.901.701.67
Martin-1.9915.8948.0930.0729.88
Ulcer0.501.584.913.563.673.40

Astellas Pharma Inc. (4503) Price Performance

Astellas Pharma Inc. (4503) trades on Tokyo Stock Exchange in JPY. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at JPY2607.00, up 0.27% from the previous close.

Over the past year, 4503 has traded between a low of JPY1281.85 and a high of JPY2657.50. The stock has gained 103.4% over this period. It is currently 103.4% above its 52-week low.

Astellas Pharma Inc. has a market capitalization of $3.94T.

About Astellas Pharma Inc.

Astellas Pharma Inc. is a Japan-based pharmaceutical company dedicated to improving global health through the development and distribution of innovative and reliable medical products. The company operates in various regions, with revenue increasing across all markets. In July 2023, Astellas acquired IVERIC bio, Inc., further strengthening its pharmaceutical portfolio and commitment to advancing patient care worldwide.

Company Info

Exchange
Tokyo Stock Exchange
Currency
JPY
Country
Japan

Financial Metrics

Revenue (TTM)
N/A
EBITDA
N/A
Profit Margin
N/A
EPS (TTM)
N/A
Book Value
N/A

Technical Indicators

52 Week High
¥2,717.00
52 Week Low
¥1,259.40
50 Day MA
¥2,449.65
200 Day MA
¥1,908.79
Beta
N/A

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
N/A
Price/Book
N/A
Enterprise Value
$3.94T